Company Filing History:
Years Active: 2021-2024
Title: The Innovative Contributions of Wan-Fen Li
Introduction
Wan-Fen Li is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibody drug conjugates. With a total of 2 patents to his name, his work focuses on innovative solutions for cancer therapies and diagnostics.
Latest Patents
Wan-Fen Li's latest patents include groundbreaking research on conjugated biological molecules and pharmaceutical compositions. His work on antibody drug conjugates (ADCs) involves a drug conjugated to antibody or antigen binding fragments that specifically target Globo series antigens. These methods of use are particularly relevant for cancer therapies and diagnostics. The antibodies developed in his research can bind to various cancer cell surfaces, targeting a wide range of carcinomas, including but not limited to sarcoma, skin cancer, leukemia, lymphoma, and many others.
Career Highlights
Wan-Fen Li is currently associated with Obi Pharma Inc., where he continues to advance his research in the field of cancer treatment. His innovative approaches have the potential to significantly impact the effectiveness of cancer therapies.
Collaborations
Some of his notable coworkers include Jiann-Shiun Lai and I-Ju Chen, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Wan-Fen Li's contributions to biotechnology and cancer treatment through his patents and research are noteworthy. His innovative work continues to pave the way for advancements in medical therapies.